Immunological Approaches to the Study of Viral Antigens Associated with Neoplasms

  • Paul Gerber
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 1969)

Abstract

Advances in tumor virology and tumor immunology during the past 6 years or so have been characterized by 2 major achievements. One was the demonstration that in some SV40-induced tumors the entire viral genome may persist in the transformed cells in a non-infectious and non-antigenic state (1). The other landmark was the discovery in most virus-induced tumors of 2 types of antigens—the transplantation antigens located on the cell surface and the intracellular T- or neoantigens. Both of these antigens are considered to be products specified by the viral genome, suggesting that most virus-induced tumors are characterized by the persistence of a portion of the viral genome as a heritable factor in the transformed cells (2).

Keywords

Lymphoma Leukemia Sarcoma Interferon Cane 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gerber, P. and Kirschstein, R. L.: SV40-induced ependymomas in newborn hamsters. Virology 18:582, 1962.Google Scholar
  2. 2.
    Huebner, R. J., Rowe, W. P., Turner, H. C. and Lane, W. T.: Specific adenovirus complement-fixing antigens in virus-free hamster and rat tumors. Proc. Nat. Acad. Sc. (US) 50:379, 1963.CrossRefGoogle Scholar
  3. 3.
    Watkins, J. F. and Dulbecco, R.: Production of SV40 virus in heterokaryons of transformed and susceptible cells. Proc. Nat. Acad. Sc. (US) 58:1396, 1967.CrossRefGoogle Scholar
  4. 4.
    Gerber, P.: Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology 25:501, 1966.CrossRefGoogle Scholar
  5. 5.
    Svoboda, J., Chyle, P. and Simkovic, D.: Demonstration of the absence of infectious Rous virus in rat tumor XC whose structurally intact cells produce Rous sarcoma when transferred to chick. Folia Biol. 9:77, 1963.Google Scholar
  6. 6.
    Habel, K.: Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc. Soc. Exp. Biol. & Med. 106:722, 1961.Google Scholar
  7. 7.
    Sjogren, H. O., Hellstrôm, I. and Klein, G.: Transplantation of polyoma virus- induced tumors in mice. Cane. Res. 21:329, 1961.Google Scholar
  8. 8.
    Defendi, V.: Effect of SV40 immunization on growth of transplantation SV40 and polyoma tumors in hamsters. Proc. Soc. Exp. Biol. & Med. 113:12, 1963.Google Scholar
  9. 9.
    Trentin, J. J. and Bryan, E.: Immunization of hamsters and histoisogenic mice against transplantation of tumors induced by human adenovirus type 12. Proc. Am. Assoc. Cane. Res. 5:64, 1964.Google Scholar
  10. 10.
    Sachs, L.: Transplantability of an X-ray-induced and virus-induced leukemia in isologous mice inoculated with leukemia virus. J. Nat. Cane. Inst. 29:759, 1962.Google Scholar
  11. 11.
    Klein, G., Clifford, P., Klein, G. and Stjernsward, J.: Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc. Nat. Acad. Sc. (US) 55:1628, 1966.CrossRefGoogle Scholar
  12. 12.
    Klein, G., Pearson, G., Henle, G., Henle, W., Diehl, V. and Niederman, J. C.: Relation between EB virus and cell membrane immunofluorescence in Burkitt tumor cells. J. Exp. Med. 128:1021–1030, 1968.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1969

Authors and Affiliations

  • Paul Gerber
    • 1
  1. 1.Laboratory of Viral Immunology Division of Biologics StandardsNational Institutes of HealthBethesdaUSA

Personalised recommendations